A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Clinical trial NCT06298565 · RECRUITING

Trial details

NCT number: NCT06298565
Sponsor: argenx
Status: RECRUITING
Study type: OBSERVATIONAL

Myasthenia Gravis

Start date: 2024-11-04
Primary completion: 2034-06-01
Enrollment: 680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.